期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2022; 33 (1)
The aim of this study was to explore the molecular pathogenesis of two families with compound heterozygous hereditary factor XI deficiency. All the ex......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2022; 33 (1)
Human coagulation factor IX (FIX) is a vitamin K dependent glycoprotein. It is used in therapy of factor IX deficiency, known as haemophilia B. This a......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2022; 33 (7)
The platelets play a crucial role in the progression of multiple medical conditions, such as stroke and tumor metastasis, where antiplatelet therapy m......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2022; 33 (7)
Thromboprophylaxis is the cornerstone strategy for thrombotic antiphospholipid syndrome (APS). Data comparing direct oral anticoagulants (DOACs) to Vi......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2022; 33 (6)
The objective of the study was to analyse a novel F13A1 gene mutation in a Chinese patient with factor XIII (FXIII) deficiency and explore the molecul......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2021; 32 (2)
The current study aims to explore the phenotype and genotype of a novel mutation (Ser951LeufsTer8) of F5 gene combined with polymorphism (R485K) in a ......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2021; 32 (4)
Introduction Early diagnosis of disseminated intravascular coagulation (DIC) before its progression to an overt stage is beneficial for its treatment ......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2021; 32 (2)
Glanzmann thrombasthenia is a rare autosomal recessive genetic disease characterized by platelet aggregation dysfunction caused by a congenital defect......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2021; 32 (5)
Congenital factor VII deficiency (FVIID) is a rare F7 gene mutation causing bleeding disorder inherited in an autosomal recessive manner. In this stud......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2021; 32 (6)
To analyse F11 gene mutations in a Chinese pedigree with hereditary factor XI (FXI) deficiency and investigate the molecular mechanism. The plasma FXI......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2021; 32 (1)
To determine if there is a significant association between administration of tranexamic acid (TXA) in severely bleeding, injured patients, and venous ......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2021; 32 (3)
The purpose is to evaluate the algorithm of Anticlot Assistant, a novel anticoagulant management system based on mobile health technology which was de......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2021; 32 (6)
The aim of this study was to elucidate the molecular defects of a Chinese family with hereditary coagulation factor XII (FXII) deficiency. The FXII ac......
期刊： BLOOD COAGULATION & FIBRINOLYSIS, 2021; 32 (1)
The aim of the report was t o explore the phenotype and genotype of a hereditary antithrombin deficient Chinese family. Functional and molecular analy......
